These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Experimental models of Parkinson's disease: insights from many models. Tolwani RJ; Jakowec MW; Petzinger GM; Green S; Waggie K Lab Anim Sci; 1999 Aug; 49(4):363-71. PubMed ID: 10480640 [TBL] [Abstract][Full Text] [Related]
6. An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Johnson ME; Bobrovskaya L Neurotoxicology; 2015 Jan; 46():101-16. PubMed ID: 25514659 [TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease. Falk T; Zhang S; Sherman SJ Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875 [TBL] [Abstract][Full Text] [Related]
8. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Uversky VN Cell Tissue Res; 2004 Oct; 318(1):225-41. PubMed ID: 15258850 [TBL] [Abstract][Full Text] [Related]
9. Generation of a alpha-synuclein-based rat model of Parkinson's disease. Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315 [TBL] [Abstract][Full Text] [Related]
10. Animal models of Parkinson's disease: An updated overview. Gubellini P; Kachidian P Rev Neurol (Paris); 2015 Nov; 171(11):750-61. PubMed ID: 26343921 [TBL] [Abstract][Full Text] [Related]
11. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Schober A Cell Tissue Res; 2004 Oct; 318(1):215-24. PubMed ID: 15503155 [TBL] [Abstract][Full Text] [Related]
12. In vivo, in vitro and pharmacologic models of Parkinson's disease. Salari S; Bagheri M Physiol Res; 2019 Mar; 68(1):17-24. PubMed ID: 30433804 [TBL] [Abstract][Full Text] [Related]
13. Gene-environment interactions in Parkinson's disease. Ross CA; Smith WW Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256 [TBL] [Abstract][Full Text] [Related]
14. Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Cicchetti F; Drouin-Ouellet J; Gross RE Trends Pharmacol Sci; 2009 Sep; 30(9):475-83. PubMed ID: 19729209 [TBL] [Abstract][Full Text] [Related]
15. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351 [TBL] [Abstract][Full Text] [Related]
16. A model of MPTP-induced Parkinson's disease in the goldfish. Weinreb O; Youdim MB Nat Protoc; 2007; 2(11):3016-21. PubMed ID: 18007638 [TBL] [Abstract][Full Text] [Related]
17. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Carvey PM; Punati A; Newman MB Cell Transplant; 2006; 15(3):239-50. PubMed ID: 16719059 [TBL] [Abstract][Full Text] [Related]
18. A guide to neurotoxic animal models of Parkinson's disease. Tieu K Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a009316. PubMed ID: 22229125 [TBL] [Abstract][Full Text] [Related]
19. Paraquat and Parkinson's disease. Berry C; La Vecchia C; Nicotera P Cell Death Differ; 2010 Jul; 17(7):1115-25. PubMed ID: 20094060 [TBL] [Abstract][Full Text] [Related]
20. Marmoset monkey models of Parkinson's disease: which model, when and why? Eslamboli A Brain Res Bull; 2005 Dec; 68(3):140-9. PubMed ID: 16325013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]